0002035832
Company

Aktis Oncology, Inc.

Pharmaceutical Preparations · AKTS

follow-on trading priced Nasdaq 424B4

Filing Timeline

SEC EDGAR
424B4 priced
424B4
SEC filing captured from the submission timeline.
2026-01-09 · 0001193125-26-009078
CERT inactive
CERT
SEC filing captured from the submission timeline.
2026-01-08 · 0001354457-26-000020
EFFECT effective
EFFECT
SEC filing captured from the submission timeline.
2026-01-08 · 9999999995-26-000113
S-1/A amended
S-1/A
SEC filing captured from the submission timeline.
2026-01-07 · 0001193125-26-005437
8-A12B effective
8-A12B
SEC filing captured from the submission timeline.
2026-01-07 · 0001193125-26-006265
S-1/A amended
S-1/A
SEC filing captured from the submission timeline.
2026-01-05 · 0001193125-26-001466
S-1 filed
S-1
SEC filing captured from the submission timeline.
2025-12-19 · 0001193125-25-326780
DRS/A amended
DRS/A
SEC filing captured from the submission timeline.
2025-11-14 · 0001193125-25-282912
DRS/A amended
DRS/A
SEC filing captured from the submission timeline.
2025-05-22 · 0000950123-25-005856
DRS/A amended
DRS/A
SEC filing captured from the submission timeline.
2024-12-13 · 0000950123-24-012257
DRS/A amended
DRS/A
SEC filing captured from the submission timeline.
2024-11-22 · 0000950123-24-012069
DRS filed
DRS
SEC filing captured from the submission timeline.
2024-10-11 · 0000950123-24-009664

Recent News

No recent news stored for this issuer.